Stay updated with breaking news from Breaking Poster. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-24-Month Open Label Extension Data from HOPE-2 Study Supports CAP-1002’s Sustained Efficacy and Safety in Treating Duchenne Muscular Dystrophy--C...
/PRNewswire/ -- Results from two studies evaluating the impact of mental health support for diabetes patients found significant benefits in patient outcomes...
Endocrine Society President to Present Crinetics CEO with John D. Baxter Prize for EntrepreneurshipSAN DIEGO, June 09, 2023 -- Crinetics Pharmaceuticals, Inc. today announced upcoming... | June 9, 2023